Shenzhen New Industries Biomedical (300832) — Capital Reinvestment Ratio

Latest as of September 2025: 0.08x

Shenzhen New Industries Biomedical (300832) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥606.21 Million) in capital expenditures (CN¥45.78 Million). Check Shenzhen New Industries Biomedical (300832) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥606.21 Million
CNY

Capital Expenditures

CN¥45.78 Million
CNY

Data as of

Sep 2025
Most recent filing

Shenzhen New Industries Biomedical Capital Reinvestment Ratio (2012–2024)

This chart tracks Shenzhen New Industries Biomedical's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Shenzhen New Industries Biomedical (300832) cash conversion ratio.

Annual Capital Reinvestment Ratio for Shenzhen New Industries Biomedical (2012–2024)

Year-by-year Capital Reinvestment Ratio for Shenzhen New Industries Biomedical from 2012 to 2024. See 300832 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.32x CN¥1.36 Billion CN¥439.20 Million ▲ +42.5%
2023 0.23x CN¥1.42 Billion CN¥322.20 Million ▼ -45.8%
2022 0.42x CN¥962.39 Million CN¥403.22 Million ▼ -5.5%
2021 0.44x CN¥773.22 Million CN¥342.94 Million ▲ +70.0%
2020 0.26x CN¥976.65 Million CN¥254.82 Million ▼ -33.7%
2019 0.39x CN¥831.73 Million CN¥327.11 Million ▼ -3.1%
2018 0.41x CN¥701.97 Million CN¥284.87 Million ▲ +20.6%
2017 0.34x CN¥524.73 Million CN¥176.51 Million ▲ +192.3%
2016 0.12x CN¥486.81 Million CN¥56.03 Million ▼ -70.5%
2015 0.39x CN¥305.93 Million CN¥119.50 Million ▼ -23.4%
2014 0.51x CN¥253.47 Million CN¥129.21 Million ▼ -50.7%
2013 1.03x CN¥138.33 Million CN¥142.95 Million ▲ +368.9%
2012 0.22x CN¥55.80 Million CN¥12.30 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow